Rob PeetsDragon Pharmaceuticals IncDDD.TODON'T BUYJan 28, 2003

Nave commercial products that are being sold in China. Still has a lot of development needed.

Rob Peets

Unknown

Unlock Rating

$0.80

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Rob PeetsDragon Pharmaceuticals IncDDD.TODON'T BUYJan 28, 2003

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals